儿童期起病1型糖尿病缺血性心脏病早期死亡风险
基于约克郡儿童1型糖尿病登记数据(4382例,诊断年龄<15岁)与临床验证死亡证明链接,评估早发1型糖尿病缺血性心脏病(IHD)死亡风险。临床验证后共14例IHD死亡,标准化死亡比(SMR)为13.8(95%CI 8.2–23.3),中位死亡年龄35.1岁(范围21.9–47.9岁)。结论提示早发1型糖尿病中IHD死亡早期出现,未经临床验证的死亡证明会低估IHD死亡。
要点
- 儿童期起病1型糖尿病患者IHD死亡风险显著升高,SMR为13.8(95%CI 8.2–23.3)。
- 临床验证后IHD中位死亡年龄为35.1岁(范围21.9–47.9岁),提示早发死亡。
- 仅凭死亡证明未经临床验证会低估IHD死亡例数。
核心结论
- 儿童期起病1型糖尿病中IHD死亡早期出现,标准化死亡比显著升高。
- 未经临床验证的死亡证明数据会低估IHD死亡。
研究设计与样本
- 约克郡儿童与青少年1型糖尿病登记队列,纳入诊断年龄<15岁者,链接临床验证死亡证明数据。
主要发现
- 队列共156例死亡,临床验证前9例被归类为IHD死亡,验证后共14例IHD死亡。
- IHD死亡的SMR为13.8(95%CI 8.2–23.3),中位死亡年龄35.1岁(范围21.9–47.9岁)。
临床怎么用
- 对儿童期起病1型糖尿病患者应关注长期心血管风险,IHD死亡可在成年早期出现。
- 利用死亡证明数据评估IHD死亡时需进行临床验证以避免低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The risk of ischaemic heart disease (IHD) death in early type 1 diabetes onset was assessed using death certification data. METHODS: The Yorkshire Register of type 1 Diabetes in Children and Young People was linked to clinically validated death certification data for those diagnosed under 15 years. Standardised mortality ratios (SMRs) were calculated using the England and Wales population and IHD death rates between 1978 and 2014 by 5-year age group and sex. RESULTS: The cohort included 4382 individuals (83 097 person years). Of 156 deaths, nine were classed as IHD deaths before clinical validation. After clinical validation, 14 IHD deaths were classified, with an SMR of 13.8 (95% CI 8.2 to 23.3) and median age at death of 35.1 years (range 21.9â€"47.9 years). CONCLUSIONS: There is an early emergence of death from IHD in early onset type 1 diabetes. Underascertainment of IHD deaths was present without clinical validation of death certification.
引用
- Evans-Cheung TC, Bodansky HJ, Parslow RC, et al. Early deaths from ischaemic heart disease in childhood-onset type 1 diabetes. Arch Dis Child. 2018. PMID: 29367262. doi:10.1136/archdischild-2017-314265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。